Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome
Clinical trial NCT03560011 · SUSPENDED
Trial details
- NCT number
- NCT03560011
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- SUSPENDED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-03
- Primary completion
- 2021-01-07
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.